Marijuana Reclassification Shakes Up Cannabis Industry

The U.S. Department of Justice has announced a pivotal reclassification of FDA-approved and state-licensed marijuana, deeming it a less-dangerous drug. Acting Attorney General Todd Blanche confirmed the department is moving marijuana from Schedule I to Schedule III, a decision that stops short of legalizing it nationwide.

Blanche posted on X that the reclassification would facilitate extensive research into marijuana's potential uses. The Justice Department is also fast-tracking a hearing to consider further rescheduling, marking a significant shift in federal stance on marijuana policy.

This change is poised to revolutionize the cannabis industry by reducing tax obstacles and simplifying funding access. Cannabinoid firms, including Canopy Growth, Tilray Brands, and Trulieve Cannabis, stand to benefit. Notably, shares of marijuana companies surged in premarket trading, signaling investor optimism.